
Summary:
In this podcast, recorded at the 2024 Patients as Partners Europe meeting, Sanofi's Victoria DiBiaso explores how pharma can evolve their patient-centric approaches in order to face challenges with prolonged timelines and heightened scrutiny on evidence generation, and to meet patient expectations of engagement.
More specifically, this podcast focuses on:
- Distinctions between merely being patient-centered and achieving a fully integrated approach
- How a fully integrated patient disease strategy is distinguished from traditional patient-centered engagement
- How sponsors effectively measure, and transparently communicate, the impact of their collaborations with patients, ensuring accountability and fostering trust
- Catalysts that drive transformative progress
- Ineffective practices to avoid
For more information on modernizing clinical research, visit DPHARMconference.com. For more information about patient centricity in clinical research, visit patientsaspartners.org.
Related Podcasts
View All
Tufts Center for Study of Drug Development on Evolving Clinical Trial Partnerships

Boehringer Ingelheim on Collaborations in Clinical Development for Launch Readiness

How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development
